PubMed

Pharmacokinetic and pharmacodynamic properties of taspoglutide, a once-weekly, human GLP-1 analogue, after single-dose administration in patients with Type 2 diabetes.

Kapitza C, Heise T, Birman P, Jallet K, Ramis J, Balena R.

Diabet Med. 2009 Nov;26(11):1156-64.PMID: 19929995 [PubMed - in process]

Treatment with the human once-weekly glucagon-like peptide-1 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone: a double-blind placebo-controlled study.

Nauck MA, Ratner RE, Kapitza C, Berria R, Boldrin M, Balena R.

Diabetes Care. 2009 Jul;32(7):1237-43. Epub 2009 Apr 14.PMID: 19366970 [PubMed - indexed for MEDLINE]Related articlesFree article

Aquaporins in skeletal muscle: reassessment of the functional role of aquaporin-4.

Frigeri A, Nicchia GP, Balena R, Nico B, Svelto M.

FASEB J. 2004 May;18(7):905-7. Epub 2004 Mar 19.PMID: 15033928 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of early postmenopausal bone loss with cyclical etidronate.

Adami S, Bruni V, Bianchini D, Becorpi A, Lombardi P, Campagnoli C, Ferrari A, Marchesoni T, Balena R.

J Endocrinol Invest. 2000 May;23(5):310-6.PMID: 10882149 [PubMed - indexed for MEDLINE]Related articles

Cyclical etidronate therapy for prevention of postmenopausal bone loss: a 1-year open-label follow-up study.

Fogelman I, Herd RJ, Blake GM, Balena R.

Calcif Tissue Int. 2000 May;66(5):348-54.PMID: 10773104 [PubMed - indexed for MEDLINE]Related articles

The effects of cyclical etidronate on early postmenopausal bone loss: an open, randomized controlled study.

Heath DA, Bullivant BG, Boiven C, Balena R.

J Clin Densitom. 2000 Spring;3(1):27-33.PMID: 10745299 [PubMed - indexed for MEDLINE]Related articles

Effects of different regimens of sodium fluoride treatment for osteoporosis on the structure, remodeling and mineralization of bone.

Balena R, Kleerekoper M, Foldes JA, Shih MS, Rao DS, Schober HC, Parfitt AM.

Osteoporos Int. 1998;8(5):428-35.PMID: 9850350 [PubMed - indexed for MEDLINE]Related articles

Mineralized bone loss at different sites in dialysis patients: implications for prevention.

Schober HC, Han ZH, Foldes AJ, Shih MS, Rao DS, Balena R, Parfitt AM.

J Am Soc Nephrol. 1998 Jul;9(7):1225-33.PMID: 9644632 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of early postmenopausal bone loss with cyclical etidronate therapy (a double-blind, placebo-controlled study and 1-year follow-up)

Meunier PJ, Confavreux E, Tupinon I, Hardouin C, Delmas PD, Balena R.

J Clin Endocrinol Metab. 1997 Sep;82(9):2784-91. Erratum in: J Clin Endocrinol Metab 1997 Nov;82(11):3740. PMID: 9284696 [PubMed - indexed for MEDLINE]Related articlesFree article

The prevention of early postmenopausal bone loss by cyclical etidronate therapy: a 2-year, double-blind, placebo-controlled study.

Herd RJ, Balena R, Blake GM, Ryan PJ, Fogelman I.

Am J Med. 1997 Aug;103(2):92-9.PMID: 9274891 [PubMed - indexed for MEDLINE]Related articles

Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study.

Delmas PD, Balena R, Confravreux E, Hardouin C, Hardy P, Bremond A.

J Clin Oncol. 1997 Mar;15(3):955-62.PMID: 9060533 [PubMed - indexed for MEDLINE]Related articles

Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones.

Masarachia P, Weinreb M, Balena R, Rodan GA.

Bone. 1996 Sep;19(3):281-90.PMID: 8873969 [PubMed - indexed for MEDLINE]Related articles

Long-term safety of the aminobisphosphonate alendronate in adult dogs. II. Histomorphometric analysis of the L5 vertebrae.

Balena R, Markatos A, Seedor JG, Gentile M, Stark C, Peter CP, Rodan GA.

J Pharmacol Exp Ther. 1996 Jan;276(1):277-83.PMID: 8558443 [PubMed - indexed for MEDLINE]Related articles

Differentiating between orchiectomized rats and controls using measurements of trabecular bone density: a comparison among DXA, histomorphometry, and peripheral quantitative computerized tomography.

Rosen HN, Tollin S, Balena R, Middlebrooks VL, Beamer WG, Donohue LR, Rosen C, Turner A, Holick M, Greenspan SL.

Calcif Tissue Int. 1995 Jul;57(1):35-9.PMID: 7671163 [PubMed - indexed for MEDLINE]Related articles

Comparison of alendronate and sodium fluoride effects on cancellous and cortical bone in minipigs. A one-year study.

Lafage MH, Balena R, Battle MA, Shea M, Seedor JG, Klein H, Hayes WC, Rodan GA.

J Clin Invest. 1995 May;95(5):2127-33.PMID: 7738180 [PubMed - indexed for MEDLINE]Related articlesFree article

Bone density is normal in male rats treated with finasteride.

Rosen HN, Tollin S, Balena R, Middlebrooks VL, Moses AC, Yamamoto M, Zeind AJ, Greenspan SL.

Endocrinology. 1995 Apr;136(4):1381-7.PMID: 7895648 [PubMed - indexed for MEDLINE]Related articles

Endogenous calcitonin attenuates parathyroid hormone-induced cancellous bone loss in the rat.

Yamamoto M, Seedor JG, Rodan GA, Balena R.

Endocrinology. 1995 Feb;136(2):788-95.PMID: 7835311 [PubMed - indexed for MEDLINE]Related articles

The role of prostaglandins in bone formation.

Harada SI, Balena R, Rodan GA, Rodan SB.

Connect Tissue Res. 1995;31(4):279-82.PMID: 15612368 [PubMed - indexed for MEDLINE]Related articles

Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.

Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rodan GA, Costantini F.

EMBO J. 1994 Mar 1;13(5):1189-96.PMID: 8131749 [PubMed - indexed for MEDLINE]Related articlesFree article

The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.

Balena R, Toolan BC, Shea M, Markatos A, Myers ER, Lee SC, Opas EE, Seedor JG, Klein H, Frankenfield D, et al.

J Clin Invest. 1993 Dec;92(6):2577-86.PMID: 8254015 [PubMed - indexed for MEDLINE]Related articlesFree article

The effects of the aminobisphosphonate alendronate on thyroid hormone-induced osteopenia in rats.

Yamamoto M, Markatos A, Seedor JG, Masarachia P, Gentile M, Rodan GA, Balena R.

Calcif Tissue Int. 1993 Oct;53(4):278-82.PMID: 8275357 [PubMed - indexed for MEDLINE]Related articles

Bisphosphonates in the treatment of metabolic bone diseases.

Rodan GA, Balena R.

Ann Med. 1993 Aug;25(4):373-8. Review.PMID: 8217103 [PubMed - indexed for MEDLINE]Related articles

Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats.

Lauritzen DB, Balena R, Shea M, Seedor JG, Markatos A, Le HM, Toolan BC, Myers ER, Rodan GA, Hayes WC.

J Bone Miner Res. 1993 Jul;8(7):871-9.PMID: 8352069 [PubMed - indexed for MEDLINE]Related articles

The aminobisphosphonate alendronate inhibits bone loss induced by thyroid hormone in the rat. Comparison between effects on tibiae and vertebrae.

Balena R, Markatos A, Gentile M, Masarachia P, Seedor JG, Rodan GA, Yamamoto M.

Bone. 1993 May-Jun;14(3):499-504.PMID: 8363899 [PubMed - indexed for MEDLINE]Related articles

The effects of three different demineralization agents on osteopontin localization in adult rat bone using immunohistochemistry.

Frank JD, Balena R, Masarachia P, Seedor JG, Cartwright ME.

Histochemistry. 1993 Apr;99(4):295-301.PMID: 8500993 [PubMed - indexed for MEDLINE]Related articles

Preclinical pharmacology of alendronate.

Rodan GA, Seedor JG, Balena R.

Osteoporos Int. 1993;3 Suppl 3:S7-12. Review.PMID: 8298203 [PubMed - indexed for MEDLINE]Related articles

Bone resorption and formation on the periosteal envelope of the ilium: a histomorphometric study in healthy women.

Balena R, Shih MS, Parfitt AM.

J Bone Miner Res. 1992 Dec;7(12):1475-82.PMID: 1481733 [PubMed - indexed for MEDLINE]Related articles

Fluorides and osteoporosis.

Kleerekoper M, Balena R.

South Med J. 1992 Aug;85(8):2S34-42. Review.PMID: 1502610 [PubMed - indexed for MEDLINE]Related articles

Hypophosphatemic rickets with hypocalciuria following long-term treatment with aluminum-containing antacid.

Foldes J, Balena R, Ho A, Parfitt AM, Kleerekoper M.

Bone. 1991;12(2):67-71.PMID: 2064842 [PubMed - indexed for MEDLINE]Related articles

Fluorides and osteoporosis.

Kleerekoper M, Balena R.

Annu Rev Nutr. 1991;11:309-24. Review.PMID: 1892703 [PubMed - indexed for MEDLINE]Related articles